About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Austin | 7,641 Studies Near You

Clinical TrialsAustin

Clinical Trials in Austin

Discover 7,641 clinical trials near Austin, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4501-4520 of 7,641 trials

RecruitingA Study to Evaluate INCA035784 in Participants With Myeloproliferative NeoplasmsThis study is being conducted to evaluate the safety and tolerability of INCA035784 in participants with myeloproliferative neoplasms.NCT07008118·Phoenix, Arizona and 25 others CompletedStudy of HemoCare™ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRDThis prospective multi-center, open-label, single-arm study intends to gather and evaluate safety data for the nocturnal use of the HemoCare™ Hemodialysis System.NCT04087213·Jackson, Mississippi and 7 others

Find Trials by Condition in Austin

Breast Cancerin Austin Lung Cancerin Austin Prostate Cancerin Austin Colorectal Cancerin Austin Melanomain Austin Leukemiain Austin Lymphomain Austin Pancreatic Cancerin Austin Ovarian Cancerin Austin Brain Cancerin Austin Diabetesin Austin

Data from ClinicalTrials.govTerms

Enrolling by invitationContinuation Protocol for Obstructive Sleep Apnea (OSA)The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep apnea (OSA).NCT06566820·Birmingham, Alabama and 98 others

RecruitingAn Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current ManiaThe primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving manic symptoms in adults with bipolar I disorder who are…NCT07288320·Little Rock, Arkansas and 10 others

Active not recruitingA Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLCThe primary objective of this study is to describe the antitumor activity of tarlatamab in participants with small cell lung cancer (SCLC).NCT06745323·Los Angeles, California and 77 others

TerminatedStudy of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)Determining the efficacy, based upon overall survival, of ruxolitinib added to capecitabine for the treatment of advanced or metastatic pancreatic cancer.NCT02117479·Avondale, Arizona and 229 others

CompletedStudy of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)This is a phase 2 randomized, double -masked study comparing the efficacy of EYP-1901 at 2 dose levels: 2060 microgram (mcg) and 3090 mcg against aflibercept.NCT05381948·Phoenix, Arizona and 66 others

RecruitingShield Post-Approval Study ProtocolThe Shield post-approval study (PAS) is a prospective, longitudinal study supplemented with Real World Evidence (RWE) to evaluate the longitudinal performance of Shield in an…NCT06880055·Chandler, Arizona and 68 others

RecruitingA Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell CarcinomaThe goal of this study is to understand whether CRB-701, a targeted form of chemotherapy called an anti-body drug conjugate, will work as a treatment for oropharyngeal (throat…NCT07768189·Huntsville, Alabama and 110 others

Active not recruitingTesting MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast CancerThis randomized phase III trial studies how well pembrolizumab works in treating patients with triple-negative breast cancer.NCT02954874·Birmingham, Alabama and 918 others

CompletedAssessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3The objective of this study is to compare the safety and efficacy of RGN-259 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.NCT03937882·Phoenix, Arizona and 19 others

CompletedExploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an AntidepressantTo evaluate the efficacy of SPD489 when used as augmentation to an antidepressant in the treatment of major depressive disorder (MDD) as measured by mean change in total…NCT00905424·Newport Beach, California and 14 others

CompletedStudy of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)SCORE2 is a multicenter, prospective, randomized, phase III clinical trial in which all participants enrolled will be followed for up to 2.5 years.NCT01969708·Phoenix, Arizona and 71 others

CompletedAn 8 Week Study Of Depression In Adults Diagnosed With Major Depressive DisorderA Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Medication in Patients with Major Depressive Disorder (MDD)NCT00057213·Peoria, Arizona and 20 others

Enrolling by invitationA Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating DisorderThis is a Phase 3, multi-center, open-label and randomized withdrawal study to evaluate the long-term safety and efficacy of solriamfetol in the treatment of binge eating disorder…NCT06878976·Encino, California and 32 others

RecruitingA Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)The purpose of this study is to assess the efficacy and safety of opevesostat plus daily corticosteroids compared to alternative abiraterone acetate or enzalutamide in…NCT06136650·Tucson, Arizona and 329 others

CompletedET-01 in Subjects With Lateral Canthal Lines, LCL-207This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).NCT03655691·Miami, Florida and 5 others

CompletedA Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerThe purpose of this study is to further quantify the risk of cerebrovascular events (CVEs) following sipuleucel-T (PROVENGE®) therapy, and to follow all subjects for survival.NCT01306890·Bessemer, Alabama and 332 others

CompletedPhase 1a/1b BGB-290 for Advanced Solid Tumors.The study contains Phase 1A and Phase 1B.NCT02361723·Gosford, New South Wales and 6 others

Active not recruitingStudy of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular DegenerationThe Phase 1 safety study of VOY-101 is comprised of escalating dose Cohorts, followed by a Phase 2 at the recommended phase 2 dose.NCT06087458·Scottsdale, Arizona and 15 others

PreviousPage 226 of 383Next

Heart Diseasein Austin